Fundz

Gedeon Richter to acquire Mayne Pharma at $6.40/share

Nov 16, 2026

Acquiring Company

Gedeon Richter

Acquired Company

Mayne Pharma Group Limited

HungaryManufacturingHealth CarePharmaceuticalBiotechnologyHealth CarePharmaceutical

Description

Gedeon Richter has made a $6.40 per share takeover bid for Mayne Pharma. This offer reflects a significant premium to Mayne Pharma's recent stock prices.

Quick answer

Gedeon Richter is acquiring Mayne Pharma Group Limited, announced November 16, 2026. Gedeon Richter is based in Hungary.

How much did Gedeon Richter pay for Mayne Pharma Group Limited?
The deal value was not disclosed.
What does Gedeon Richter do?
Gedeon Richter is a leading global pharmaceutical company, dedicated to improving accessibility to medicines worldwide.
Where are Gedeon Richter and Mayne Pharma Group Limited based?
Gedeon Richter is based in Hungary.
Who are the decision-makers at Gedeon Richter?
Fundz holds 1 contact at Gedeon Richter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Pharmaceutical and Pharmaceutical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Gedeon Richter, and when

When Gedeon Richter changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Gedeon Richter raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gedeon Richter, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gedeon Richter. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gedeon Richter

Location

Hungary

About

Gedeon Richter is a leading global pharmaceutical company, dedicated to improving accessibility to medicines worldwide. Founded in 1901, it has established itself as a key innovator in neuropsychiatry and women's healthcare. The company operates Central Europe's largest R&D hub, showcasing its commitment to medical innovation. It focuses on sustainable growth through investments in research and development, manufacturing, and digitalization.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gedeon Richter makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gabor
Likely contact at this company
••••••••@••••••••

See Gabor's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gedeon Richter's next move

Learn about Strategic plan

Frequently asked

Who acquired Mayne Pharma Group Limited?

Mayne Pharma Group Limited was acquired by Gedeon Richter, based in Hungary. The deal was reported on November 16, 2026. Gedeon Richter is a leading global pharmaceutical company, dedicated to improving accessibility to medicines worldwide. Gedeon Richter is privately held and operates in Manufacturing.

When did Gedeon Richter acquire Mayne Pharma Group Limited?

Gedeon Richter's acquisition of Mayne Pharma Group Limited was reported on November 16, 2026. Gedeon Richter has made a $6.40 per share takeover bid for Mayne Pharma. This offer reflects a significant premium to Mayne Pharma's recent stock prices. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Mayne Pharma Group Limited do?

Mayne Pharma Group Limited is a pharmaceutical company based in Australia. It has a proven commercial expertise and is known for its strength in women's health and dermatology. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.